All Deals
September 13, 2024 - Deals
Cavela Raises $2M In Funding Round Led By XYZ Venture Capital With Propel Ventures And Go Global
Cavela, a San Francisco-based AI-powered platform, raised $2M in a funding round led by XYZ Venture Capital, with participation from Propel Ventures and Go Global Ventures. Founded and led by CEO Anthony Sardain, Cavela helps businesses optimize supplier matching and negotiation through AI-driven automation, significantly reducing the time and effort involved in sourcing products from premium manufacturers worldwide. The funds will support the company's growth and further platform development.
INVESTORS: XYZ Venture Capital, Propel Ventures & Go Global Ventures
AMOUNT: $2,000,000
HQ: #SanFrancisco #California
#VentureCapital #Cavela #XYZVentureCapital #PropelVenturesandGoGlobalVentures #AnthonySardain #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC